What is DARWIN EU?
Healthcare ECONOMIST
NOVEMBER 14, 2022
By supporting decision-making on the development, authorisation and surveillance of medicines, a wide range of stakeholders will benefit, from patients and healthcare professionals to health technology assessment bodies and the pharmaceutical industry. Arlett et al.
Let's personalize your content